AAF-CMK
AAF-CMK is a TPPII (tripeptidylpeptidase II) inhibitor, shows anti-tumor activity and induces apoptosis. AAF-CMK can be used in leukemia research[1].
Product Specifications
CAS Number
102129-66-8
UNSPSC
12352209
Target
Apoptosis; Ser/Thr Protease
Type
Peptides
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/aaf-cmk.html
Solubility
10 mM in DMSO
Smiles
C[C@H](N)C(N[C@@H](C)C(N[C@H](C(CCl)=O)CC1=CC=CC=C1)=O)=O
Molecular Formula
C16H22ClN3O3
Molecular Weight
339.82
References & Citations
[1]Młnarczuk I, et al. AAF-cmk sensitizes tumor cells to trail-mediated apoptosis. Leuk Res. 2004 Jan;28 (1) :53-61.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
